Loviselli A, Bartalena L, Balzano S, Aghini-Lombardi F, Sica V, Pilosu R, Petrini L, Giannessi G, Buratti L, Martino E
Istituto di Medicina Interna, Università di Cagliari, Italy.
J Endocrinol Invest. 1988 Apr;11(4):323-5. doi: 10.1007/BF03350159.
The role of iodine in the pathogenesis of thyroid hormone autoantibodies (THAA) was evaluated in a large series (n = 223) of patients submitted to chronic treatment (3-36 months) with the iodine-rich drug, amiodarone. Positive anti-T3 autoantibody (AbT3) tests were found only in one patient, whereas tests for anti-T4 autoantibody (AbT4) were negative in all cases. Likewise, the incidence of THAA in the control groups of patients with spontaneous thyroid disorders was low. The overall prevalence of THAA in the present series of 803 patients was 1.2% for AbT3 and 0.1% for AbT4. The present data strongly suggest that iodine plays a minor role, if any, in the occurrence of THAA.
在一大组(n = 223)接受富碘药物胺碘酮长期治疗(3 - 36个月)的患者中,评估了碘在甲状腺激素自身抗体(THAA)发病机制中的作用。仅在1例患者中发现抗T3自身抗体(AbT3)检测呈阳性,而所有病例的抗T4自身抗体(AbT4)检测均为阴性。同样,自发性甲状腺疾病患者对照组中THAA的发生率也很低。在本系列803例患者中,AbT3的THAA总体患病率为1.2%,AbT4为0.1%。目前的数据有力地表明,碘在THAA的发生中即使有作用,也是次要的。